Kasten, Inc., known commercially as DAKOTA Life Sciences, operates as a biopharmaceutical firm. Its primary endeavors involve obtaining, advancing, and bringing to market therapeutic agents crafted to avert and mitigate severe medical conditions prevalent in both hospital and general community environments. A significant aspect of its mission is to provide affordable and accessible pharmaceutical solutions, especially for individuals grappling with antimicrobial resistance.